Identifying risk factors for rubella susceptibility in a population at risk in the United States.
Danovaro-Holliday
M Carolina
MC
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.
Gordon
Ely R
ER
Woernle
Charles
C
Higginbotham
Gary H
GH
Judy
Randa H
RH
Icenogle
Joseph P
JP
Reef
Susan E
SE
D000328:Adult; D000407:Alabama / Q000453:epidemiology; D000914:Antibodies, Viral / Q000097:blood; D004196:Disease Outbreaks; D004198:Disease Susceptibility / Q000208:ethnology / Q000276:immunology; D005260:Female; D019649:Food Industry; D006801:Humans; D017589:Immunization Programs; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage; D017058:Mexican Americans; D012307:Risk Factors; D012409:Rubella / Q000208:ethnology* / Q000276:immunology* / Q000517:prevention & control; D012410:Rubella Syndrome, Congenital / Q000208:ethnology / Q000276:immunology / Q000517:prevention & control; D012412:Rubella virus / Q000276:immunology; D000078329:Workforce
D000914:Antibodies, Viral; D022542:Measles-Mumps-Rubella Vaccine